Recombinant Interferon α2a, Thymopentin and Low Doses of Cytosine Arabinoside for the Treatment of Myelodysplastic Syndromes: A Pilot Study

Adriano Venditti, Maria Teresa Scimo, Giovanni Del Poeta, Francesco Buccisano, Roberto Stasi, Antonio Mastino, Sandro Grelli, Cartesio Favalli, Enrico Garaci, Giuseppe Papa

Open source

DOI: 10.3109/10428199509049773
Published: 1995-01
Container: Leukemia & Lymphoma
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3109/10428199509049773,
  title = {Recombinant Interferon α2a, Thymopentin and Low Doses of Cytosine Arabinoside for the Treatment of Myelodysplastic Syndromes: A Pilot Study},
  author = {Adriano Venditti and Maria Teresa Scimo and Giovanni Del Poeta and Francesco Buccisano and Roberto Stasi and Antonio Mastino and Sandro Grelli and Cartesio Favalli and Enrico Garaci and Giuseppe Papa},
  year = {1995},
  journal = {Leukemia \&amp; Lymphoma},
  doi = {10.3109/10428199509049773},
  url = {https://doi.org/10.3109/10428199509049773}
}

RIS

TY  - JOUR
TI  - Recombinant Interferon α2a, Thymopentin and Low Doses of Cytosine Arabinoside for the Treatment of Myelodysplastic Syndromes: A Pilot Study
AU  - Adriano Venditti
AU  - Maria Teresa Scimo
AU  - Giovanni Del Poeta
AU  - Francesco Buccisano
AU  - Roberto Stasi
AU  - Antonio Mastino
AU  - Sandro Grelli
AU  - Cartesio Favalli
AU  - Enrico Garaci
AU  - Giuseppe Papa
PY  - 1995
JO  - Leukemia &amp; Lymphoma
DO  - 10.3109/10428199509049773
UR  - https://doi.org/10.3109/10428199509049773
ER  -

APA

Venditti, A., Scimo, M. T., Poeta, G. D., Buccisano, F., Stasi, R., Mastino, A., Grelli, S., Favalli, C., Garaci, E., & Papa, G. (1995). Recombinant Interferon α2a, Thymopentin and Low Doses of Cytosine Arabinoside for the Treatment of Myelodysplastic Syndromes: A Pilot Study. Leukemia & Lymphoma. https://doi.org/10.3109/10428199509049773

Source records

crossref · retrieved 2026-09-25T08:16:47.450Z